Ray continued, “We’re also delighted to acknowledge Martin and Greg’s contributions to Synthekine with their new roles. Martin’s deep insights into cytokine biology and immunology were instrumental to shaping the development of STK-012, our first-in-class alpha/beta biased IL-2. Its exceptional system expands the therapeutic index of IL-2, one of The https://https-www-zosanopharma-co43210.mdkblog.com/42602255/the-2-minute-rule-for-https-www-zosanopharma-com-technology